In this March 16, 2020, file photo, the subject is given a modalized vaccine for COVID-19 in a first-stage safety study clinical trial by Moderna, a disease caused by the new coronavirus, at the Kaiser Permanent Washington Health Research Institute in Seattle. Ted S and War Run | A.P. On …
Read More »The COVID-19 vaccine candidates from Moderna and Pfizer need ultra-low temperatures, raising questions about storage, distribution
The COVID-19 vaccine candidates developed by Moderna Inc. and BioNTech and Pfizer Inc. will require strict standards for cooling, and that may hinder how they are distributed to the hundreds of millions of Americans who expect to receive them. Shares of Modern MRNA, -3.54% were 3.6% lower in trading on …
Read More »Plasma treatment of Covid-19 might help, not perform at home
Dr. Scott Gottlieb told CNBC on Monday that the treatment of blood plasma for patients with coronavirus just getting permission for emergency services by the Trump administration may have been somewhat effective. “I think this could be beneficial. It could be weakly beneficial,” Gottlieb said on “Squawk Box.” “It does …
Read More »Pfizer vaccine on track for regulatory review in October
Johnson & Johnson to begin a fax trial with 60,000 people in September
A Johnson & Johnson building is on display in Irvine, California. Mike Blake | Reuters Johnson & Johnson are planning to begin what would be the biggest, in the late-stage trial testing a potential coronavirus vaccine in September, the company confirmed Thursday. The phase three trial would enroll up to …
Read More »